Cytokinetics says Lou Gehrig's drug fails mid-stage trial
April 25, 2014 at 07:52 AM EDT
April 25 (Reuters) - Cytokinetics Inc said its experimental treatment for Lou Gehrig's disease - a progressive neurodegenerative disorder - failed the main goal in a mid-stage trial.
